Title
Category
Credits
Event date
Cost
- Mandated Reporter
- 1.00 AMA PRA Category 1 Credit™
$0.00
The state of Illinois has specific requirements for mandated reporter training. In this webinar – which has been designed to meet the training mandate set forth by the state of Illinois – Dr. Norell Rosado of Lurie Children’s Hospital’s Division of Child Abuse Pediatrics and ISMIE’s Chief Legal Officer and Chief Compliance Officer, Robert John Kane, JD, will discuss the indicators for child abuse and neglect, the importance of responding to a child in a trauma-informed manner, and the process and responsibilities of a mandated reporter in the state of Illinois.
- Palliative Care
- End of Life Care
- 1.00 AANP Contact Hours
- 0.75 AANP Pharmacology Contact Hours
- 1.00 AMA PRA Category 1 Credit™
$0.00
All seriously ill patients can benefit from palliative care principles in the primary care setting. This session is designed to offer clinicians the information and skills needed to provide high-quality primary palliative care to patients with serious illness. Participants will develop a toolbox of palliative care competencies including pain and symptom management and serious illness communication skills.
- Suicide
- 1.00 AMA PRA Category 1 Credit™
$0.00
Suicide was declared a public health crisis by the U.S. Surgeon General in 1999. However, suicide rates continued to climb over the past two decades by a staggering 35% (1999-2018). Fortunately, we have seen decreases in the national suicide rates from 2018-2020. The pandemic’s impact on mental health is a major focus of public health concern and while distress and mental health suffering have increased, the suicide rate in the US actually decreased by 3% from 2019 to 2020.
- Cognitive Impairment
- 0.58 AANP Contact Hours
- 0.50 AMA PRA Category 1 Credit™
$0.00
In the context of a patient case presentation, expert faculty will highlight the stages of Alzheimer disease (AD) and the vital importance of early detection of mild cognitive impairment (MCI). They will discuss screening for MCI and current guidelines and standards of care for establishing a diagnosis of AD. The faculty will also examine the effects of increasingly more accessible neuroimaging and fluid markers on the diagnosis of AD, especially with the recent FDA approvals of anti-amyloid therapies.
- Addiction Medicine
- Substance Use Disorder (SUD)
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
$0.00
Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.
- Addiction Medicine
- Substance Use Disorder (SUD)
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
$0.00
Each lesson in the Disease Management Clinical Decisions series provides a brief, case-based review of management strategies related to the topic. Questions and multiple-choice answers about the case presented include the rationale for the correct answer. Throughout this case-based lesson, you may proceed to the next question once you answer the question correctly.
- Pharmacology
- Gender-affirming Care
- LGBTQ
- 1.00 AANP Contact Hours
- 1.00 AANP Pharmacology Contact Hours
- 1.00 AMA PRA Category 1 Credit™
$0.00
This engaging session explores primary care for gender-diverse individuals. Through practical case studies, clinicians will navigate gender-affirming hormone therapies (GAHTs), including the benefits, complications, and comprehensive care strategies for patients. Enhance your expertise in supporting diverse patient populations.
- Palliative Care
- Buprenorphine
- Opioid Use Disorder (OUD)
- Pain Management
- 1.00 AMA PRA Category 1 Credit™
$0.00
In this recorded Palliative Care Educational Series presentation, palliative care and addiction medicine specialist Dr. Janet Ho provides a comprehensive overview on the use of buprenorphine, a partial opioid agonist, for pain management and treatment of opioid use disorder. Dr. Ho begins with an overview of buprenorphine's pharmacology, including its unique properties as a partial agonist with a strong binding affinity to the mu-opioid receptor, its ceiling effect on respiratory depression, and its ability to reduce hyperalgesia and cravings. Dr.
- Antimicrobial Stewardship
- 7.00 AMA PRA Category 1 Credit™
$0.00
Internet Enduring Material provided by Stanford University School of Medicine. Presented by the Division of Infectious Diseases and Geographic Medicine at Stanford University School of Medicine. Sponsored by the Stanford University School of Medicine.